Rebecca Chota Nelson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rebecca Chota Nelson has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Michael S. Benninger
Cleveland Clinic Voice Center, Department of Otolaryngology Head and Neck Institute, Cleveland Clinic Cleveland Ohio USA
2 shared publications - Paul C. Bryson
Cleveland Clinic Lerner College of Medicine;Case Western Reserve University, USA
2 shared publications - Claudio F. Milstein
Head and Neck Institute, Cleveland Clinic, 9500 Euclid Avenue - Desk A-71, Cleveland, OH 44195, USA
1 shared publication Claudio Milstein
Head and Neck Institute, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A.
1 shared publication- Erika Woodson
12 Cleveland Clinic Head and Neck Institute, Cleveland, Ohio, USA
1 shared publication Michael S. Benninger
Head and Neck Institute, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A.
1 shared publication
Latest Publications
- 14 January 2021
- Published by Taylor & Francis in Cochlear Implants International
- Vol. 22 (3) , 148-156
Initial hearing preservation outcomes of cochlear implantation with a slim perimodiolar electrode array
To assess the slim modiolar array as a hearing preservation electrode. Retrospective chart review of adult, post-lingual CI recipients implanted with slim modiolar array Sept 2016 to July 2017 in a...
- 14 January 2021
- Published by Taylor & Francis in Cochlear Implants International
- Vol. 22 (3) , 148-156
Initial hearing preservation outcomes of cochlear implantation with a slim perimodiolar electrode array
To assess the slim modiolar array as a hearing preservation electrode. Retrospective chart review of adult, post-lingual CI recipients implanted with slim modiolar array Sept 2016 to July 2017 in a...
- 19 February 2020
- Published by Wiley in The Laryngoscope
- Vol. 130 (12) , 2843-2846
Respiratory Laryngeal Dystonia: Characterization and Diagnosis of a Rare Neurogenic Disorder
Objectives/Hypothesis: Respiratory laryngeal dystonia (RLD) is poorly understood and rarely reported in the literature. Patients have atypical laryngeal movement resulting in airway obstruction. This motion is neurogenic in nature, is constant while awake, nonepisodic, and non–trigger dependent. Given its rarity, it is often misdiagnosed for inducible laryngeal obstruction; however, it is refractory to medical and behavioral management. Although this condition has been addressed in the literature, this report is the largest case series characterizing presenting symptomology, multimodal treatment outcomes, and longitudinal course of these patients, and proposes a set of diagnostic criteria to aid in clinical identification of RLD patients. Our objectives were to characterize RLD clinically and offer diagnostic guidelines to clinicians.Study Design: A prospective case series with a retrospective analysis at a tertiary referral center.Methods: A review of clinical records and videostroboscopic analysis of 16 patients treated for respiratory laryngeal dystonia from October 2005 to October 2018 was performed.Results: Sixteen patients with respiratory laryngeal dystonia were included. The common features of this group were persistent, nonepisodic dyspnea and stridor with laryngoscopic evidence of paradoxical vocal fold motion. Our patients had no structural neurologic abnormalities. These patients typically failed respiratory retraining therapy and medical management of laryngeal irritants. In our series, 100% of patients underwent respiratory retraining therapy, 68.8% received laryngeal botulinum toxin injection, and 31.3% required tracheostomy.Conclusions: RLD is a rare and challenging condition. The disorder can be severely disabling, and treatment options appear limited. A multidisciplinary approach may be helpful. Some patients responded to laryngeal botulinum injection and medical management, whereas others required tracheostomy for symptom control. Laryngoscope, 2020
- 19 February 2020
- Published by Wiley in The Laryngoscope
- Vol. 130 (12) , 2843-2846
Respiratory Laryngeal Dystonia: Characterization and Diagnosis of a Rare Neurogenic Disorder
Objectives/Hypothesis: Respiratory laryngeal dystonia (RLD) is poorly understood and rarely reported in the literature. Patients have atypical laryngeal movement resulting in airway obstruction. This motion is neurogenic in nature, is constant while awake, nonepisodic, and non–trigger dependent. Given its rarity, it is often misdiagnosed for inducible laryngeal obstruction; however, it is refractory to medical and behavioral management. Although this condition has been addressed in the literature, this report is the largest case series characterizing presenting symptomology, multimodal treatment outcomes, and longitudinal course of these patients, and proposes a set of diagnostic criteria to aid in clinical identification of RLD patients. Our objectives were to characterize RLD clinically and offer diagnostic guidelines to clinicians.Study Design: A prospective case series with a retrospective analysis at a tertiary referral center.Methods: A review of clinical records and videostroboscopic analysis of 16 patients treated for respiratory laryngeal dystonia from October 2005 to October 2018 was performed.Results: Sixteen patients with respiratory laryngeal dystonia were included. The common features of this group were persistent, nonepisodic dyspnea and stridor with laryngoscopic evidence of paradoxical vocal fold motion. Our patients had no structural neurologic abnormalities. These patients typically failed respiratory retraining therapy and medical management of laryngeal irritants. In our series, 100% of patients underwent respiratory retraining therapy, 68.8% received laryngeal botulinum toxin injection, and 31.3% required tracheostomy.Conclusions: RLD is a rare and challenging condition. The disorder can be severely disabling, and treatment options appear limited. A multidisciplinary approach may be helpful. Some patients responded to laryngeal botulinum injection and medical management, whereas others required tracheostomy for symptom control. Laryngoscope, 2020
- 27 December 2018
- Published by Wiley in The Laryngoscope
- Vol. 129 (6) , 1433-1437
Laryngeal Botulinum Toxin Injection for Vocal Tremor: Utility of Concurrent Strap Muscle Injection
Objectives/Hypothesis: Vocal tremor is a neurologic disorder that can be treated with laryngeal botulinum toxin injections (LBTX). We sought to describe our experience with thyroarytenoid and concurrent strap muscle injection.Study Design: Retrospective chart review.Methods: A chart review was performed of all patients with a primary diagnosis of vocal tremor treated with LBTX from 2012 through 2017.Results: Twenty‐one patients were included (mean age 69 years, 100% female). Thirteen patients (62%) had a minor component of spasmodic dysphonia in addition to their tremor. Fourteen patients had vertical and horizontal components to their tremor, and two had horizontal tremor alone. The remaining five patients did not have clear characterization of their tremor. A total of 49 injections were reviewed (25 thyroarytenoid [TA], 24 thyroarytenoid and strap muscle [TA+S]), and patients reported subjective voice benefit with 48 (96%) of these (92% TA, 100% TA+S). When available, the postprocedural change from baseline Voice Handicap Index‐10 and Consensus Auditory Perceptual Evaluation of Voice scores were calculated (mean overall: −1.9, −7.8; TA: −2.7, −3.5; TA+S: −1.4, −10.3, respectively). Subjective patient improvement ratings (scale 0%–100%) were obtained for 46 injections, with a mean of 70% improvement per injection. Of patients with both horizontal and vertical tremor, outcomes were improved with TA+S injection versus TA alone (mean improvement 74% vs. 35%, P < .005).Conclusions: There is utility in the characterization of vertical and horizontal components of vocal tremor. Patients with both appear to have increased benefit with injection of strap muscles in addition to thyroarytenoid muscles.Level of Evidence: 4Laryngoscope, 129:1433–1437, 2019
- 27 December 2018
- Published by Wiley in The Laryngoscope
- Vol. 129 (6) , 1433-1437
Laryngeal Botulinum Toxin Injection for Vocal Tremor: Utility of Concurrent Strap Muscle Injection
Objectives/Hypothesis: Vocal tremor is a neurologic disorder that can be treated with laryngeal botulinum toxin injections (LBTX). We sought to describe our experience with thyroarytenoid and concurrent strap muscle injection.Study Design: Retrospective chart review.Methods: A chart review was performed of all patients with a primary diagnosis of vocal tremor treated with LBTX from 2012 through 2017.Results: Twenty‐one patients were included (mean age 69 years, 100% female). Thirteen patients (62%) had a minor component of spasmodic dysphonia in addition to their tremor. Fourteen patients had vertical and horizontal components to their tremor, and two had horizontal tremor alone. The remaining five patients did not have clear characterization of their tremor. A total of 49 injections were reviewed (25 thyroarytenoid [TA], 24 thyroarytenoid and strap muscle [TA+S]), and patients reported subjective voice benefit with 48 (96%) of these (92% TA, 100% TA+S). When available, the postprocedural change from baseline Voice Handicap Index‐10 and Consensus Auditory Perceptual Evaluation of Voice scores were calculated (mean overall: −1.9, −7.8; TA: −2.7, −3.5; TA+S: −1.4, −10.3, respectively). Subjective patient improvement ratings (scale 0%–100%) were obtained for 46 injections, with a mean of 70% improvement per injection. Of patients with both horizontal and vertical tremor, outcomes were improved with TA+S injection versus TA alone (mean improvement 74% vs. 35%, P < .005).Conclusions: There is utility in the characterization of vertical and horizontal components of vocal tremor. Patients with both appear to have increased benefit with injection of strap muscles in addition to thyroarytenoid muscles.Level of Evidence: 4Laryngoscope, 129:1433–1437, 2019
- 1 May 2015
- Published by Elsevier in Journal of Voice
- Vol. 29 (3) , 363-369
Custom Implants for Medialization Laryngoplasty: A Model That Considers Tissue Compression
- 1 May 2015
- Published by Elsevier in Journal of Voice
- Vol. 29 (3) , 363-369
Custom Implants for Medialization Laryngoplasty: A Model That Considers Tissue Compression